Arcus Biosciences Correlations

RCUS Stock  USD 16.44  0.50  3.14%   
The current 90-days correlation between Arcus Biosciences and Cullinan Oncology LLC is 0.31 (i.e., Weak diversification). The correlation of Arcus Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Arcus Biosciences Correlation With Market

Weak diversification

The correlation between Arcus Biosciences and DJI is 0.38 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Arcus Biosciences and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Arcus Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
For more information on how to buy Arcus Stock please use our How to Invest in Arcus Biosciences guide.

Moving against Arcus Stock

  0.47VERA Vera TherapeuticsPairCorr
  0.41VCEL Vericel Corp OrdPairCorr
  0.36VCYT VeracytePairCorr
  0.35DVAX Dynavax TechnologiesPairCorr
  0.33VTRS ViatrisPairCorr
  0.32DYAI Dyadic InternationalPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
INZYCGEM
XFORCGEM
INZYRLAY
XFORRLAY
INZYXFOR
PTCTVECT
  
High negative correlations   
VECTXFOR
PTCTINZY
PTCTRLAY
VECTRLAY
PTCTCGEM
PTCTXFOR

Risk-Adjusted Indicators

There is a big difference between Arcus Stock performing well and Arcus Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Arcus Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
CGEM  2.90 (0.72) 0.00 (0.23) 0.00 
 5.88 
 17.85 
ANNX  2.59 (0.33) 0.00 (0.07) 0.00 
 6.98 
 23.00 
GPCR  2.89 (0.18) 0.00 (0.18) 0.00 
 8.18 
 24.50 
RLAY  3.39 (0.78) 0.00 (0.09) 0.00 
 4.82 
 66.18 
DAWN  2.03 (0.05)(0.03) 0.05  2.73 
 3.84 
 11.44 
ABOS  3.58 (0.48) 0.00 (0.06) 0.00 
 7.52 
 28.07 
XFOR  5.11 (0.54) 0.00 (0.26) 0.00 
 8.82 
 62.35 
INZY  2.78 (1.17) 0.00 (0.60) 0.00 
 5.07 
 16.62 
VECT  2.63  1.16  0.54 (2.61) 0.88 
 5.61 
 39.30 
PTCT  2.73  0.50  0.19  0.49  2.35 
 7.02 
 23.95